News - Proximagen

Filter

Current filters:

Proximagen

Popular Filters

UK's Proximagen boosted by US lorcaserin news with respect to its own obesity drug candidate

14-05-2012

UK-based biotechnology firm Proximagen (AIM: PRX) saw its shares leap 20.1% to 257.5 pence, on the back…

BiotechnologyMetabolicsProximagenRegulationResearch

Proximagen boasts strong cash balance, updates on R&D

05-03-2012

UK-based CNS and inflammatory diseases specialist Proximagen (AIM: PRX) has announced its unaudited preliminary…

FinancialPharmaceuticalProximagenResearch

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm

30-09-2011

Danish central nervous system specialist Lundbeck (LUND: DC) and the UK’s Proximagen Group (AIM:…

LundbeckMergers & AcquisitionsNeurologicalPharmaceuticalProximagenResearch

Back to top